High Quality Undervalued Stocks

Results

232

29 new
This selection of undervalued companies are the market's hidden engines of wealth. Not only do they combine good cash flows with and a solid balance sheet, but they are also poised for a breakout.

232 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
STX
US$795.471.6%638.0%US$180.5bUS$814.9575.036.6%0.4%Tech
APP
US$501.006.9%38.3%US$163.0bUS$644.4743.021.6%n/aSoftware
AIR
€167.68-6.8%4.6%€136.0b€209.3126.315.7%1.9%Capital Goods
285A
JP¥44,450.00-0.09%1,901.4%JP¥24.3tJP¥40,935.71145.364.9%n/aSemiconductors
4519
JP¥7,938.000.5%5.5%JP¥13.1tJP¥10,096.6728.912.5%1.7%Pharmaceuticals & Biotech
MELI
US$1,546.81-5.3%-40.2%US$81.5bUS$2,236.2840.827.1%0%Retail
LITE
US$970.707.4%1,145.3%US$71.8bUS$1,104.68158.579.1%n/aTech
VOLV B
SEK 317.20-2.0%15.0%SEK 646.3bSEK 340.3119.614.2%4.1%Capital Goods
NU
New
US$12.19-11.7%-6.6%US$62.8bUS$19.545.220.3%n/aBanks
SE
US$88.231.7%-45.4%US$54.1bUS$140.3733.723.9%n/aRetail
2259
HK$153.00-11.3%n/aHK$409.5bHK$249.7623.318.3%1.0%Materials
300476
New
CN¥340.22-5.1%342.0%CN¥329.3bCN¥439.4071.449.4%0.6%Tech
GALD
CHF 156.65-4.4%55.3%CHF 37.1bCHF 182.4076.424.1%0.2%Pharmaceuticals & Biotech
2345
NT$2,505.005.5%249.9%NT$1.4tNT$2,852.2047.433.1%0.6%Tech
FITB
US$47.35-4.0%19.5%US$43.2bUS$57.401.322.5%3.4%Banks
3037
NT$821.000.4%704.9%NT$1.3tNT$870.82120.754.0%0.2%Tech
STLD
US$229.34-2.5%70.2%US$33.8bUS$238.8224.120.7%0.9%Materials
WAT
US$329.22-7.3%-8.4%US$32.7bUS$399.8171.924.4%n/aPharmaceuticals & Biotech
ADYEN
€890.80-5.5%-45.6%€28.1b€1,399.2426.415.6%n/aDiversified Financials
2408
NT$311.5013.7%582.4%NT$965.2bNT$305.6427.939.4%0%Semiconductors
002463
New
CN¥102.99-5.3%233.9%CN¥198.2bCN¥110.3746.128.6%0.5%Tech
NST
AU$20.50-3.1%10.6%AU$29.3bAU$27.3818.921.1%2.9%Materials
1801
HK$82.00-8.9%60.8%HK$142.3bHK$116.38152.030.9%n/aPharmaceuticals & Biotech
STMN
CHF 83.62-1.3%-25.9%CHF 13.3bCHF 106.7837.416.0%1.2%Healthcare
Page 1 of 7